Systelligence LLC’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-33,460
Closed -$2.04M 50
2021
Q2
$2.04M Sell
33,460
-6,827
-17% -$391K 0.54% 36
2021
Q1
$2.32M Sell
40,287
-101,540
-72% -$6.35M 0.65% 34
2020
Q4
$8.33M Buy
141,827
+76,668
+118% +$4.14M 1.78% 21
2020
Q3
$3.1M Buy
65,159
+20,342
+45% +$923K 0.94% 36
2020
Q2
$2M Buy
+44,817
New +$1.79M 0.65% 44

Other funds holding BTEC

Systelligence LLC's BTEC Position: Q3 2021 in Review

Systelligence LLC sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2021, closing a stake of 33,460 shares — an estimated $2.04M sold.

Systelligence LLC first reported a position in BTEC in Q2 2020 and held it in 5 quarters. The position peaked at $8.33M in Q4 2020. 31 funds tracked by Wall St. Rank hold BTEC as of Q3 2021.

  • Systelligence LLC reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2021 after selling out during the quarter.
  • Systelligence LLC sold 33,460 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2021, an estimated $2.04M.
  • Systelligence LLC first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q2 2020 and held it in 5 quarters.
  • Systelligence LLC's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $8.33M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2021.

Based on Systelligence LLC's 13F filing for Q3 2021, filed 26 Oct 2021.